3rd Quarter - Report

AMERICAN PHARMACISTS ASSOCIATION for AMERICAN PHARMACISTS ASSOCIATION

Firm
Client
Income
—
Expenses
$35,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Alcohol and Drug Abuse ALC

H.R. 1384/S. 445 -- Mainstreaming Addiction Treatment Act

LobbyistCovered position, as disclosed
MICHAEL BAXTER New —
ALICIA KERRY J. MICA —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 1384 (117th), S. 445 (117th)

Medicare/Medicaid MMM

H.R. 2759/S. 1362 -- the Pharmacy and Medically Underserved Areas Enhancement Act, legislation to recognize pharmacists and their services in Medicare Part B. H.R. 7213 -- This bill expands Medicare coverage to permanently include services provided by a pharmacist, including incidental services and supplies, related to testing, drug regimens, and vaccines for COVID-19, influenza, and certain other illnesses.

LobbyistCovered position, as disclosed
MICHAEL BAXTER New —
ALICIA KERRY J. MICA —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 2759 (117th), H.R. 7213 (117th), S. 1362 (117th)

Pharmacy PHA

H.R. 7213 - To amend title XVIII of the Social Security Act to provide pharmacy reimbursement for COVID-19-related and future emergency services. S 4293 - Pharmacy Benefit Manager Transparency Act of 2022

LobbyistCovered position, as disclosed
MICHAEL BAXTER New —
ALICIA KERRY J. MICA —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 7213 (117th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.